Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Abilify Lawsuit Filed in New York for Child with Diabetes

Abilify Lawsuit Filed in New York for Child with Diabetes

September 9, 2014 — A lawsuit has been filed in federal court in New York by a woman who was prescribed Abilify (aripiprazole) as a child and subsequently developed type-2 diabetes, according to Law360.

The lawsuit (PDF) was filed in the U.S. District Court for the Southern District of New York against Bristol-Myers Squibb Co. and Otsuka American Pharmaceutical Inc., the manufacturer and distributor of Abilify.

The plaintiff, Cheyenne Beth Confer, says her doctor prescribed Abilify “off-label” to treat her depression. She started taking Abilify in May 2009 when she was just 15 years old.

Within six months, she gained 30 pounds and was diagnosed with diabetes — a chronic metabolic condition that requires lifelong medical care. She now must take metformin to control blood-sugar levels.

According to a complaint, defendants failed to warn that children on the average recommended dose of Abilify were 7.7-times more likely to be diagnosed with diabetes. The complaint also accuses defendants of failing to update the Prescribing Information to include data from studies published since 2005.

The Prescribing Information only includes general information about a possible association between anti-psychotic drugs and diabetes. However, it states that there is no evidence linking Abilify with diabetes or changes in fasting blood-sugar (glucose) levels in children with schizophrenia, bipolar disorder, or irritability.

The lawsuit alleges that children could be more sensitive to the metabolic side effects of Abilify, such as rapid weight-gain.

The complaint further alleges that Bristol-Myers Squibb aggressively promoted Abilify “off-label” for unapproved uses in children between 2002 and 2005. In September 2007, Bristol-Myers Squibb agreed to pay $515 million to resolve allegations about improper marketing. The U.S. Department of Justice (DOJ) accused the company of knowingly promoting Abilify for pediatric uses that were not approved by the FDA, in violation of federal law.

Do I have an Abilify Lawsuit?

The Schmidt Firm, PLLC is currently accepting Abilify induced injury cases in all 50 states. If you or somebody you know has been diagnosed with type-2 diabetes, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiff’s law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*